Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 5/2005

01.05.2005 | Clinical Investigation

Bayes’ theorem applied to perimetric progression detection in glaucoma: from specificity to positive predictive value

verfasst von: Nomdo M. Jansonius

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 5/2005

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To estimate the specificity of a clinical evaluation of a series of visual fields and to calculate the positive predictive value of progression.

Methods

The specificity of a clinical evaluation of a series of visual fields was estimated using nonparametric ranking and probability calculus. The positive predictive value of progression was calculated using Bayes’ theorem. The literature suggests a prior probability of progression of typically 0.10 in the case of one visual field per year. Three different prior probability values were used: 0.05, 0.10, and 0.20. Calculations were performed for a sensitivity of 0.50, 0.80, and 1.00.

Results

Specificity of a clinical evaluation of a series of visual fields was calculated as 0.83 for four fields (two baseline fields, one follow-up field with suspected progression, and one confirmation of the suspected progression), 0.90 for five fields, and 0.95 for six fields. Positive predictive values ranged from 0.14 to 0.83. Positive predictive value was approximately 0.5 for a prior probability of 0.10, a sensitivity of 0.80, and a specificity of 0.90.

Conclusions

Realistic series of visual fields that are apparently progressive have a positive predictive value of typically 0.5, i.e., half of them are stable. In the case of a high prior probability (uncontrolled glaucoma or long interval between successive fields), four fields may suffice to diagnose progression, whereas at least six fields are required if the prior probability is low.
Literatur
1.
Zurück zum Zitat AGIS investigators (1994) Advanced glaucoma intervention study 2: visual field test scoring and reliability. Ophthalmology 101:1445–1455 AGIS investigators (1994) Advanced glaucoma intervention study 2: visual field test scoring and reliability. Ophthalmology 101:1445–1455
2.
Zurück zum Zitat Altman DG (1991) Practical statistics for medical research. Chapman & Hall, London Altman DG (1991) Practical statistics for medical research. Chapman & Hall, London
3.
Zurück zum Zitat Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310PubMed Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307–310PubMed
4.
Zurück zum Zitat Chauhan BC, Drance SM, Douglas GR (1990) The use of visual field indices in detecting changes in the visual field in glaucoma. Invest Ophthalmol Vis Sci 31:512–520PubMed Chauhan BC, Drance SM, Douglas GR (1990) The use of visual field indices in detecting changes in the visual field in glaucoma. Invest Ophthalmol Vis Sci 31:512–520PubMed
5.
Zurück zum Zitat Esterman B (1968) Grid for scoring visual fields. Arch Ophthalmol 79:400–406PubMed Esterman B (1968) Grid for scoring visual fields. Arch Ophthalmol 79:400–406PubMed
6.
Zurück zum Zitat Fitzke FW, Hitchings RA, Poinoosawmy D, McNaught AI, Crabb DP (1996) Analysis of visual field progression in glaucoma. Br J Ophthalmol 80:40–48PubMed Fitzke FW, Hitchings RA, Poinoosawmy D, McNaught AI, Crabb DP (1996) Analysis of visual field progression in glaucoma. Br J Ophthalmol 80:40–48PubMed
7.
Zurück zum Zitat Gardiner SK, Crabb DP (2002) Frequency of testing for detecting visual field progression. Br J Ophthalmol 86:560–564CrossRefPubMed Gardiner SK, Crabb DP (2002) Frequency of testing for detecting visual field progression. Br J Ophthalmol 86:560–564CrossRefPubMed
8.
Zurück zum Zitat Heijl A, Leske MC, Bengtsson B, Bengtsson B, Hussein M, EMGT group (2003) Measuring visual field progression in the early manifest glaucoma trial. Acta Ophthalmol Scand 81:286–293CrossRefPubMed Heijl A, Leske MC, Bengtsson B, Bengtsson B, Hussein M, EMGT group (2003) Measuring visual field progression in the early manifest glaucoma trial. Acta Ophthalmol Scand 81:286–293CrossRefPubMed
9.
Zurück zum Zitat Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, EMGT group (2002) Reduction of intraocular pressure and glaucoma progression. Arch Ophthalmol 120:1268–1279PubMed Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, EMGT group (2002) Reduction of intraocular pressure and glaucoma progression. Arch Ophthalmol 120:1268–1279PubMed
10.
Zurück zum Zitat Heijl A, Lindgren G, Lindgren A, Olsson J, Asman P, Myers S, Patella M (1990) Extended empirical statistical package for evaluation of single and multiple fields in glaucoma: Statpac 2. In: Mills RP, Heijl A (eds) Perimetry update 1990/1. Kugler, New York, pp 305–315 Heijl A, Lindgren G, Lindgren A, Olsson J, Asman P, Myers S, Patella M (1990) Extended empirical statistical package for evaluation of single and multiple fields in glaucoma: Statpac 2. In: Mills RP, Heijl A (eds) Perimetry update 1990/1. Kugler, New York, pp 305–315
11.
Zurück zum Zitat Heijl A, Lindgren G, Olsson J (1986) A package for the statistical analysis of visual fields. Doc Ophthalmol Proc Ser 49:153–168 Heijl A, Lindgren G, Olsson J (1986) A package for the statistical analysis of visual fields. Doc Ophthalmol Proc Ser 49:153–168
12.
Zurück zum Zitat Katz J, Congdon N, Friedman DS (1999) Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment. Arch Ophthalmol 117:1137–1142PubMed Katz J, Congdon N, Friedman DS (1999) Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment. Arch Ophthalmol 117:1137–1142PubMed
13.
Zurück zum Zitat Krakau CE (1985) A statistical trap in the evaluation of visual field decay. Acta Ophthalmol Suppl 173:19–21PubMed Krakau CE (1985) A statistical trap in the evaluation of visual field decay. Acta Ophthalmol Suppl 173:19–21PubMed
14.
Zurück zum Zitat Lee AC, Sample PA, Blumenthal EZ, Berry C, Zangwill L, Weinreb RN (2002) Infrequent confirmation of visual field progression. Ophthalmology 109:1059–1065CrossRefPubMed Lee AC, Sample PA, Blumenthal EZ, Berry C, Zangwill L, Weinreb RN (2002) Infrequent confirmation of visual field progression. Ophthalmology 109:1059–1065CrossRefPubMed
15.
Zurück zum Zitat Leske MC, Heijl A, Hyman L, Bengtsson B, EMGT group (1999) Early manifest glaucoma trial: design and baseline data. Ophthalmology 106:2144–2153CrossRefPubMed Leske MC, Heijl A, Hyman L, Bengtsson B, EMGT group (1999) Early manifest glaucoma trial: design and baseline data. Ophthalmology 106:2144–2153CrossRefPubMed
16.
Zurück zum Zitat Musch DC, Lichter PR, Guire KE, Standardi CL (1999) The collaborative initial glaucoma treatment study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology 106:653–662CrossRefPubMed Musch DC, Lichter PR, Guire KE, Standardi CL (1999) The collaborative initial glaucoma treatment study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology 106:653–662CrossRefPubMed
17.
Zurück zum Zitat Smith SD, Katz J, Quigley HA (1996) Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci 37:1419–1428PubMed Smith SD, Katz J, Quigley HA (1996) Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci 37:1419–1428PubMed
18.
Zurück zum Zitat Spry PGD, Johnson CA (2002) Identification of progressive glaucomatous visual field loss. Surv Ophthalmol 47:158–173CrossRefPubMed Spry PGD, Johnson CA (2002) Identification of progressive glaucomatous visual field loss. Surv Ophthalmol 47:158–173CrossRefPubMed
19.
Zurück zum Zitat Vesti E, Johnson CA, Chauhan BC (2003) Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci 44:3873–3879CrossRefPubMed Vesti E, Johnson CA, Chauhan BC (2003) Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci 44:3873–3879CrossRefPubMed
20.
Zurück zum Zitat Viswanathan AC, Hitchings RA, Fitzke FW (1997) How often do patients need visual field tests? Graefes Arch Clin Exp Ophthalmol 235:563–568PubMed Viswanathan AC, Hitchings RA, Fitzke FW (1997) How often do patients need visual field tests? Graefes Arch Clin Exp Ophthalmol 235:563–568PubMed
Metadaten
Titel
Bayes’ theorem applied to perimetric progression detection in glaucoma: from specificity to positive predictive value
verfasst von
Nomdo M. Jansonius
Publikationsdatum
01.05.2005
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 5/2005
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-004-1065-x

Weitere Artikel der Ausgabe 5/2005

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2005 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.